Pillar5 Pharma Inc. a Contract Manufacturing Organization (CMO) founded in 2009 further to the acquisition of the former Pfizer Arnprior plant in Ontario, Canada. This plant has been in operation since 1956 with significant investment in equipment, processes and people over the many years of successful operations.
Pillar5 Pharma strive to manage complexity for our customers by offering the
following solutions:
• Supporting development programs for innovative products to enhance
speed to market
• Helping to increase value in mature products
• Developing a strategy to provide small volumes sterile ophthalmic at
effective cost
Manufacturing Capabilities:
• Ophthalmic solution compounding
• Solid Dose
• Blending
• Compression
• Encapsulation
• Fluid bed drying
• Film coating
• Low shear/High shear granulation
• Roller Compaction
Packaging Capabilities:
• Aseptic filling (Ophthalmic)
• Blister packaging lines (Alu/PVC + Alu/Alu)
• High speed solid dose equipment
• Secondary and tertiary packaging lines
• Specialty packaging for kit/samples assembly
Services in Support of Manufacturing:
• Raw material testing
• Finished product releasing
• Qualification of alternative raw material
• Microbiological testing
• Stability services (ICH Guidelines)
• PAT (NIR)
• Technical transfer/Scale-up expertise
• Validation services
The plant has been successfully inspected by Health Canada and the FDA.
